0001209191-18-018674.txt : 20180309 0001209191-18-018674.hdr.sgml : 20180309 20180309205143 ACCESSION NUMBER: 0001209191-18-018674 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180306 FILED AS OF DATE: 20180309 DATE AS OF CHANGE: 20180309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Prentiss Christopher B CENTRAL INDEX KEY: 0001717583 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 18681721 MAIL ADDRESS: STREET 1: 1900 POWELL STREET STREET 2: SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER NAME: FORMER CONFORMED NAME: Prentiss Chris DATE OF NAME CHANGE: 20170921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-06 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001717583 Prentiss Christopher B C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 0 1 0 0 Chief Accounting Officer Common Stock 2018-03-06 4 A 0 5000 0.00 A 18325 D Stock Option (Right to Buy) 25.66 2018-03-06 4 A 0 30000 0.00 A 2028-03-05 Common Stock 30000 30000 D The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2019, March 20, 2020, March 20, 2021 and March 20, 2022, subject to Reporting Person's Continuous Service as of each such date. Includes 920 shares purchased on 11/30/17 through the issuer's employee stock purchase plan. The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2018, subject to Reporting Person's Continuous Service as of each such date. /s/ Jennifer Rhodes, Attorney-in-fact 2018-03-09